Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Complement C1s-IN-1

😃Good
Catalog No. T74816Cas No. 3033831-40-9

Complement C1s-IN-1 is a potent and selective inhibitor of complement C1s with the advantage of being orally available and brain penetrable, significantly inhibiting human serum-induced formation of membrane attack complexes in a dose-dependent manner and effectively blocking the classical complement pathway

Complement C1s-IN-1

Complement C1s-IN-1

😃Good
Purity: 97.77%
Catalog No. T74816Cas No. 3033831-40-9
Complement C1s-IN-1 is a potent and selective inhibitor of complement C1s with the advantage of being orally available and brain penetrable, significantly inhibiting human serum-induced formation of membrane attack complexes in a dose-dependent manner and effectively blocking the classical complement pathway
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$1,130-In Stock
5 mg$2,270-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.77%
ee:97.68%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Complement C1s-IN-1 is a potent and selective inhibitor of complement C1s with the advantage of being orally available and brain penetrable, significantly inhibiting human serum-induced formation of membrane attack complexes in a dose-dependent manner and effectively blocking the classical complement pathway
Targets&IC50
C1s (mouse):61 nM, Other serine proteases:>30,000 nM, C1s (human):36 nM
In vitro
Complement C1s-IN-1 (compound (R)-8) is a highly selective C1s inhibitor with an IC₅₀ of 36 nM for human C1s and 61 nM for mouse C1s. Complement C1s-IN-1 showed minimal activity against other serine proteases (IC₅₀ > 30,000 nM). Complement C1s-IN-1 also dose-dependently inhibited serum-induced classical complement pathway activation in vitro[1].
In vivo
Following oral administration in mice (10–100 mg/kg), Complement C1s-IN-1 showed dose-dependent plasma exposure (Cmax up to 8895.5 ng/mL; AUC₀–₂₄h = 139,341 ng·h/mL) with a mean residence time of 7.66 h. Complement C1s-IN-1 exhibited strong brain penetration, with brain concentrations reaching 33,559.5 ng/g at 2 h and a brain/plasma ratio up to 1.7[1].
Chemical Properties
Molecular Weight422.43
FormulaC22H20F2N6O
Cas No.3033831-40-9
SmilesCC1=CC([C@@H]2N(CCN(C2)C3=CC4=C(C(F)=C3)C(N)=NN=C4)C5=CC(F)=CC=C5)=NO1
Relative Density.no data available
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Complement C1s-IN-1 | purchase Complement C1s-IN-1 | Complement C1s-IN-1 cost | order Complement C1s-IN-1 | Complement C1s-IN-1 chemical structure | Complement C1s-IN-1 in vivo | Complement C1s-IN-1 in vitro | Complement C1s-IN-1 formula | Complement C1s-IN-1 molecular weight